A detailed history of Blue Barn Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Blue Barn Wealth, LLC holds 6,558 shares of NVO stock, worth $708,329. This represents 0.42% of its overall portfolio holdings.

Number of Shares
6,558
Previous 6,435 1.91%
Holding current value
$708,329
Previous $918,000 15.03%
% of portfolio
0.42%
Previous 0.54%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$119.07 - $145.42 $14,645 - $17,886
123 Added 1.91%
6,558 $780,000
Q2 2024

Aug 05, 2024

BUY
$122.71 - $146.91 $3,558 - $4,260
29 Added 0.45%
6,435 $918,000
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $30,530 - $40,640
-299 Reduced 4.46%
6,406 $822,000
Q4 2023

Feb 06, 2024

SELL
$87.78 - $105.45 $3,072 - $3,690
-35 Reduced 0.52%
6,705 $693,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $367,306 - $805,942
4,039 Added 149.54%
6,740 $612,000
Q2 2023

Aug 08, 2023

SELL
$155.98 - $172.65 $12,790 - $14,157
-82 Reduced 2.95%
2,701 $437,000
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $7,808 - $9,389
-59 Reduced 2.08%
2,783 $442,000
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $67,067 - $88,505
654 Added 29.89%
2,842 $384,000
Q3 2022

Oct 26, 2022

BUY
$95.28 - $116.93 $19,341 - $23,736
203 Added 10.23%
2,188 $218,000
Q2 2022

Jul 29, 2022

SELL
$103.24 - $121.81 $32,107 - $37,882
-311 Reduced 13.55%
1,985 $221,000
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $9,403 - $11,366
101 Added 4.6%
2,296 $255,000
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $862 - $1,053
9 Added 0.41%
2,195 $246,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $184,542 - $233,071
2,186 New
2,186 $210,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Blue Barn Wealth, LLC Portfolio

Follow Blue Barn Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Barn Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Barn Wealth, LLC with notifications on news.